The Rotoprone therapy System is an advanced patient care system for the treatment and prevention of pulmonary complications. The Rotoprone Therapy System provides up to 62 degrees in both prone and supine positions as well as Trendelenburg/Reverse Trendelenburg positioning. Product Usage: Use of the Rotoprone Therapy System is indicated for patients with severe acute respiratory distress syndrome (ARDS). These are critical patients who are at higher risk of cardiac arrest and mortality. Placing a patient in the prone position may reopen collapsed airways and thus improve pulmonary gas exchange and respiratory mechanics.
Publicado el 12 de febrero de 2014 · Inicio del retiro: 11 de septiembre de 2013
Resumen
FDA registra el retiro Z-0926-2014 de dispositivos médicos de Clase II, publicado el 12 de febrero de 2014 e iniciado el 11 de septiembre de 2013. Empresa responsable: ArjoHuntleigh Inc.; Estado: Finalizado; Cantidad reportada: 231 units; Lote: Model #209500. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The lock pin can become stuck in the "in" position during the manual rotation, resulting in the inability to prone a patient
Qué hacer
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- ArjoHuntleigh Inc.
- Distribuidor
- US Nationwide and Middle East
- Lote
- Model #209500
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDASmartSite Needleless Connector, Model No. 2000E The SmartSite Needleless Connectors are sterile, individually12 de febrero de 2014
- FDACARESCAPE Monitor B850, a multi-parameter high acuity patient monitor intended for use in multiple areas12 de febrero de 2014
- FDAABX PENTRA Urine Control L/H. The ABX PENTRA Urine Control L/H is a two-level (Low and High) quality control12 de febrero de 2014
- FDAXiO RTP System. Used to create treatment plans for any cancer patient for whom external beam radiation therapy12 de febrero de 2014
- FDASuperElastic Regular force NiTi lower or upper Natural arches. 0.14 size 10 or 100 count packages. Highland12 de febrero de 2014
- FDAADVIA Centaur® Systems Phenytoin Calibrator N ( PHTN) 2-pack SMN 10311391 For in vitro diagnostic use in the12 de febrero de 2014
Preguntas sobre este retiro
¿The Rotoprone therapy System is an advanced patient care system for the treatment and prevention of pulmonary complications. The Rotoprone Therapy System provides up to 62 degrees in both prone and supine positions as well as Trendelenburg/Reverse Trendelenburg positioning. Product Usage: Use of the Rotoprone Therapy System is indicated for patients with severe acute respiratory distress syndrome (ARDS). These are critical patients who are at higher risk of cardiac arrest and mortality. Placing a patient in the prone position may reopen collapsed airways and thus improve pulmonary gas exchange and respiratory mechanics. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0926-2014 el 12 de febrero de 2014. Peligro reportado: The lock pin can become stuck in the "in" position during the manual rotation, resulting in the inability to prone a patient
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit